Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (561-570 of 4,678) with videos related to

Pageof 468
Sort By:
Cancer Discovery|March 12, 2013
Targeting MYCN: a good BET for improving neuroblastoma therapy?Robert W Schnepp, John M Maris
Cancer Discovery|March 12, 2013
Bcl-2 inhibition or FBXW7 mutation sensitizes solid tumor cells to HDAC inhibition in vitro but could prove difficult to validate in patientsCurtis R Pickering, Jeffrey N Myers
Cancer Discovery|March 12, 2013
AMPK can suppress tumorigenesis and the Warburg effect
Cancer Discovery|March 12, 2013
An oncogenic splice variant drives EMT and metastasis in breast cancer
Cancer Discovery|March 12, 2013
NSCLC brain metastases respond to erlotinib and radiation
Cancer Discovery|December 28, 2012
Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancerSusan M Domchek, Jiangbo Tang, Jill Stopfer, et al.
Cancer Discovery|January 10, 2013
From differences in means between cases and controls to risk stratification: a business plan for biomarker developmentNicolas Wentzensen, Sholom Wacholder
Cancer Discovery|December 15, 2012
Genotype-selective combination therapies for melanoma identified by high-throughput drug screeningMatthew A Held, Casey G Langdon, James T Platt, et al.
Cancer Discovery|December 5, 2012
ARID1A mutations in cancer: another epigenetic tumor suppressor?Jennifer N Wu, Charles W M Roberts
Cancer Discovery|December 12, 2012
Noncovalent wild-type-sparing inhibitors of EGFR T790MHo-June Lee, Gabriele Schaefer, Timothy P Heffron, et al.
Pageof 468

Showing results (561-570 of 4,678) with videos related to

Sort By:
Pageof 468
Cancer Discovery|March 12, 2013
Targeting MYCN: a good BET for improving neuroblastoma therapy?Robert W Schnepp, John M Maris
Cancer Discovery|March 12, 2013
Bcl-2 inhibition or FBXW7 mutation sensitizes solid tumor cells to HDAC inhibition in vitro but could prove difficult to validate in patientsCurtis R Pickering, Jeffrey N Myers
Cancer Discovery|March 12, 2013
AMPK can suppress tumorigenesis and the Warburg effect
Cancer Discovery|March 12, 2013
An oncogenic splice variant drives EMT and metastasis in breast cancer
Cancer Discovery|March 12, 2013
NSCLC brain metastases respond to erlotinib and radiation
Cancer Discovery|December 28, 2012
Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancerSusan M Domchek, Jiangbo Tang, Jill Stopfer, et al.
Cancer Discovery|January 10, 2013
From differences in means between cases and controls to risk stratification: a business plan for biomarker developmentNicolas Wentzensen, Sholom Wacholder
Cancer Discovery|December 15, 2012
Genotype-selective combination therapies for melanoma identified by high-throughput drug screeningMatthew A Held, Casey G Langdon, James T Platt, et al.
Cancer Discovery|December 5, 2012
ARID1A mutations in cancer: another epigenetic tumor suppressor?Jennifer N Wu, Charles W M Roberts
Cancer Discovery|December 12, 2012
Noncovalent wild-type-sparing inhibitors of EGFR T790MHo-June Lee, Gabriele Schaefer, Timothy P Heffron, et al.
Pageof 468